These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7042056)

  • 41. How we describe competitive antagonists: three questions of usage.
    Jenkinson DH
    Trends Pharmacol Sci; 1991 Feb; 12(2):53-4. PubMed ID: 2024288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo characterization of histamine H1- and H2-receptors in the rat stomach microcirculation.
    Koo A
    Br J Pharmacol; 1983 Jan; 78(1):181-9. PubMed ID: 6218851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neurokinin-3 receptor-specific antagonists talnetant and osanetant show distinct mode of action in cellular Ca2+ mobilization but display similar binding kinetics and identical mechanism of binding in ligand cross-competition.
    Tian G; Wilkins D; Scott CW
    Mol Pharmacol; 2007 Mar; 71(3):902-11. PubMed ID: 17172464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estimation of antagonist Kb from inhibition curves in functional experiments: alternatives to the Cheng-Prusoff equation.
    Lazareno S; Birdsall NJ
    Trends Pharmacol Sci; 1993 Jun; 14(6):237-9. PubMed ID: 8372404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle.
    Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW
    Br J Pharmacol; 1995 Jan; 114(2):339-48. PubMed ID: 7881733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Calcium influx-dependent and -independent alpha 1-adrenoceptor-mediated processes of vasoconstriction in vivo do not operate via different alpha 1-adrenoceptor subtypes.
    Korstanje C; Wilffert B; de Jonge A; Thoolen MJ; Timmermans PB; van Zwieten PA
    J Cardiovasc Pharmacol; 1984; 6(6):1102-8. PubMed ID: 6084766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The competitive antagonistic effect of compounds from Mandevilla velutina on kinin-induced contractions of rat uterus and guinea-pig ileum in vitro.
    Calixto JB; Pizzolatti MG; Yunes RA
    Br J Pharmacol; 1988 Aug; 94(4):1133-42. PubMed ID: 3207977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of resampling techniques to estimate the variance of parameters in pharmacological assays when experimental protocols preclude independent replication: an example using Schild regressions.
    Lutz MW; Kenakin TP; Corsi M; Menius JA; Krishnamoorthy C; Rimele T; Morgan PH
    J Pharmacol Toxicol Methods; 1995 Sep; 34(1):37-46. PubMed ID: 7496045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tachykinin NK1 receptor subtypes in the rat urinary bladder.
    Meini S; Patacchini R; Maggi CA
    Br J Pharmacol; 1994 Mar; 111(3):739-46. PubMed ID: 7517327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of NK3 receptors in rabbit isolated iris sphincter muscle.
    Medhurst AD; Parsons AA; Roberts JC; Hay DW
    Br J Pharmacol; 1997 Jan; 120(1):93-101. PubMed ID: 9117105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antagonist inhibition curves and the measurement of dissociation constants.
    Barlow RB; Bond SM; Bream E; Macfarlane L; McQueen DS
    Br J Pharmacol; 1997 Jan; 120(1):13-8. PubMed ID: 9117087
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cross-talk between AT(1) and AT(2) angiotensin receptors in rat anococcygeus smooth muscle.
    de Godoy MA; de Oliveira AM
    J Pharmacol Exp Ther; 2002 Oct; 303(1):333-9. PubMed ID: 12235268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simple pA2 estimation of partial agonists: comparison with the Kaumann-Blinks method.
    Pöch G; Zimmermann I
    J Pharmacol Methods; 1988 Mar; 19(1):47-56. PubMed ID: 3367648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Schild regression analysis of antidepressant and bicuculline antagonist effects at the GABAA receptor.
    Malatynska E; Crites G; Yochum A; Kopp R; Giroux ML; Dilsaver SC
    Pharmacology; 1998 Sep; 57(3):117-23. PubMed ID: 9691231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Errors in the measurement of agonist potency-ratios produced by uptake processes: a general model applied to beta-adrenoceptor agonists.
    Kenakin TP
    Br J Pharmacol; 1980; 71(2):407-17. PubMed ID: 6110457
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Binding characteristics of GYKI-46 903, a non-competitive ligand at 5-HT3 receptors.
    Vitális B; Sebestyén L; Sike M; Sólyom S; Hársing LG
    Pharmacol Res; 2001 Mar; 43(3):291-9. PubMed ID: 11401422
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of 5-HT receptor subtypes mediating contraction in human umbilical vein. 1. Evidence of involvement of 5-HT2A receptors using functional and radioligand binding assays.
    Rogines-Velo MP; Pelorosso FG; Zold CL; Nowak W; Pesce GO; Sardi SP; Brodsky PT; Rothlin RP
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):587-95. PubMed ID: 12444501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The assessment of antagonist potency under conditions of transient response kinetics.
    Christopoulos A; Parsons AM; Lew MJ; El-Fakahany EE
    Eur J Pharmacol; 1999 Oct; 382(3):217-27. PubMed ID: 10556673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Naloxazone treatment in the guinea pig ileum in vitro reveals second functional opioid receptor site.
    James MK; Leighton HJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):138-44. PubMed ID: 3027301
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heterogeneity of muscarinic receptors in lamb isolated coronary resistance arteries.
    Simonsen U; Prieto D; Rivera L; Hernández M; Mulvany MJ; García-Sacristán A
    Br J Pharmacol; 1993 Aug; 109(4):998-1007. PubMed ID: 8401954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.